Assessment of effectiveness and safety of minimal doses of propofol for sedation for MRI in childre
Not Applicable
- Conditions
- Health Condition 1: G80- Cerebral palsyHealth Condition 2: K00-K95- Diseases of the digestive systemHealth Condition 3: M00-M99- Diseases of the musculoskeletal system and connective tissueHealth Condition 4: G00-G99- Diseases of the nervous systemHealth Condition 5: G40- Epilepsy and recurrent seizures
- Registration Number
- CTRI/2019/11/022044
- Lead Sponsor
- OKMANYA TILAK MUNICIPAL MEDICAL COLLEGE AND LOKMANYA MUNICIPAL GENERAL HOSPITA
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. CHILDREN UNDERGOING MRI
2. AGE 1TO 9 YEARS
3. BOTH GENDERS
4. ASA STATUS (AMERICAN SOCIETY OF ANAESHESIOLOGISTS)- I AND II
5. ADEQUATE STARVATION AS PER GUIDELINES OF ASA
Exclusion Criteria
1) ASA status: III and above.
2) Active Upper respiratory tract infection.
3) Severe cardiovascular or respiratory insufficiency
4) History of propofol allergy
5) Any contraindications for Dexmedetomidine and Ketamine administration
6) Anticipated difficult airway
7) Children having active seizures.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. Awakening time <br/ ><br>2. QUALITY OF SCAN <br/ ><br>3. TOTAL DOSE OF PROPOFOLTimepoint: 1. AFTER STOPPING PROPFOL INFUSION <br/ ><br>2. AFTER MRI SCAN COMPLETION <br/ ><br>3. AFTER STOPPING PROPOFOL INFUSIO
- Secondary Outcome Measures
Name Time Method 1. ANY ADVERSE EVENTS <br/ ><br>2. ATTAIN SUCCESSFUL LEVEL OF SEDATION <br/ ><br>3. DISCHARGE TIMETimepoint: 1. THROUGHOUT THE PROCEDURE. <br/ ><br>2. TILL THE END OF MRI SCANNING <br/ ><br>3. TIME AFTER AWAKENING TIME TO DISCHARGE OF CHILD